18F-AlF-NOTA-octreotide PET/CT and 3D printing technology for precision diagnosis and treatment of phosphaturic mesenchymal tumors in patients with tumor-induced osteomalacia: two case reports
18F-AlF-NOTA-Octreotide PET/CT may be a precise diagnostic method for TIO, while 3D printing technology may serve as an effective and dependable adjunct for the treatment of PMT in patients with TIO.
Authors
- Lijuan Guan
- Ming Yang (ORCID: https://orcid.org/0000-0001-8247-4936)
- Xiaolei Ding (ORCID: https://orcid.org/0000-0001-9595-8788)
- Wenming Luo (ORCID: https://orcid.org/0009-0002-3031-4804)
- Gang Zhao (ORCID: https://orcid.org/0000-0002-9175-4291)
- Jie Zhao (ORCID: https://orcid.org/0000-0001-5280-9694)
- Qi Wang (ORCID: https://orcid.org/0000-0002-8159-0270)
- Zhen Liu (ORCID: https://orcid.org/0000-0001-7095-5548)
- Yongqiang Liu (ORCID: https://orcid.org/0000-0002-6442-5193)
- Yongqiang Zhang
- Xingzhen Shi
Institutions
- Weifang Medical University (CN)
- Weifang People's Hospital (CN)
- Changchun University of Chinese Medicine (CN)
- Stomatology Hospital (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2024-11-20
- DOI
- https://doi.org/10.3389/fendo.2024.1359975
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00